{
  "name" : "dacemirror.sci-hub.se_journal-article_5f9cd2ace0a28879dd326ee1f6b977f9_luo2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "O2-evolving and ROS-activable nanoparticles for treatment of multi-drug resistant Cancer by combination of photodynamic therapy and chemotherapy",
    "authors" : [ "Zhijian Luo", "Mingxing Li", "Meiling Zhou", "Huayun Li", "Youyou Chen", "Xiaoqun Ren", "Yan Dai" ],
    "emails" : [ "daiyan@swmu.edu.cn." ],
    "sections" : [ {
      "heading" : null,
      "text" : "Herein, a novel nano-system IF7-ROSPCNP, which is O2-evolving and reactive oxygen species (ROS)-activable, was developed for enhancing the combination chemotherapy and photodynamic therapy (PDT). The nanoparticles composed of photosensitizers (disulfonated meso-tetraphenylporphine, TPPS2a) and catalase in the inner core, doxorubicin (DOX) in the polymeric shell and functionalized on its surface with IF7 peptide, which specially bind to annexin 1. As confirmed that the structure of IF7-ROSPCNP was able to remain intact under normal physiological conditions. After IF7-ROSPCNP was selectively entrapped by the annexin 1-positive and ROS-abundant MCF-7/ADR cells, the shell of nanoparticles was ruptured and the entrapped photosensitizers were completely released out. Under irradiation, ROS was continuously produced and the DOX, which was conjugated to the terminal of polylactic copolymer (mPEG-PLA) by a ROS-cleavable linkage, was subsequently released. With such strategy, cellular uptake of drugs was dramatically improved resulted in an enhanced cytotoxicity and anti-tumor effect on drug resistant cancer. © 2019 Elsevier Inc. All rights reserved.\nKey words: Photochemical internalization; Combination treatment; Reactive oxygen species; Tumor hypoxia; Triggered release\nAs a specific arm of photodynamic therapy (PDT), photochemical internalization (PCI) has been widely developed for sitespecific delivery of chemotherapeutics and cell membrane impermeable macromolecules.1–3 Combination of PCI and chemotherapy is a technique that enhancing cytotoxicity of anti-cancerous agents to drug-resistant tumor cells. Under the photoactivation effect of photosensitizers, the membranes of organelles was disrupted, followed by driving intracellular accumulation of drugs and releasing drugs into the cytosol from endosomes or lysosomes.4 Themost unique property of combining PCI with chemotherapy is increasing the availability of the\nConflict of interest: The authors declare that no competing interests are present, and there is no conflict of interest.\nFunding: This work was supported by Doctoral Research Startup Fund of the Affiliated Hospital of Southwest Medical University (Item Number 16250).\n⁎Corresponding author. E-mail address: daiyan@swmu.edu.cn. (Y. Dai).\nhttps://doi.org/10.1016/j.nano.2019.03.007 1549-9634/© 2019 Elsevier Inc. All rights reserved.\nPlease cite this article as: Luo Z, et al, O2-evolving and ROS-activable nano photodynamic therapy and chemotherapy. Nanomedicine: NBM 2019;19:49-57\nanticancer drug at its site of action.5 Besides, such combination treatment strategy holds great potential in inducing antitumor immunity through a complex way.6\nAlthough PCI has become a promising treatment option for drug-resistant cancers, tumor hypoxia severely impaired the therapeutic efficiency and hindered the further application of PCI in clinic.7 The hypoxic environment of tumors is mainly caused by an inadequate oxygen supply and has been recognized as a characteristic feature of solid tumors.8 However, such hypoxic environment is highly detrimental to PCI application which requires sufficient molecular oxygen to continuously produce reactive oxygen species.9 To overcome such dilemma, efforts have beenmade to develop newO2-independent phototherapy agents. 10\nAnother obstacle is the limited tumor selectivity which leads to poor drug delivery efficiency and limited tumor penetration.11 To conquer these problems, active targeting strategy has been designed to enhance the delivery efficiency.12 However, release of chemotherapeutics at unspecific site seemed to be unavoidable because it is impossible to accumulate all the administrated\nparticles for treatment of multi-drug resistant Cancer by combination of , https://doi.org/10.1016/j.nano.2019.03.007\ndrugs to the targeted sites.13 Stimuli-responsive polymeric nanocarriers are therefore developed for controlled transport of active compounds.14 Incorporation of cleavable linkages, which can be degraded in response to external stimuli, into drug delivery systems represents a promising method.15 For example, ROScleavable linkage has been widely used because most tumor cells are under persistent endogenous ROS stress (50~100 μM).16\nHerein, we developed a novel nanoplatform which is ROS activable and capable of 1) simultaneously loading both of doxorubicin and photosensitizers (TPPS2a) for highly efficacious combination photodynamics therapy against the multi-drug resistant tumor, human breast cancer xenograft; 2) sealing the cytotoxicity of DOX by linking it to the terminal of mPEG-PLA-COOH via a ROS cleavable linkage; 3) encapsulating catalase which can catalyzed the intracellular H2O2 for continuous production of oxygen. Such versatile nanoplatform is formed by co-assembly of two distinct polymers with the one is DOX conjugated tri-block co-polymer, mPEG-PLA-ROS-DOX, and the other one is terminal functionalized mPEG-PLA-COOH. The DOX contained co-polymer was developed via two steps of esterification reaction and introduction of the ROS-sensitive linkage thioketal (TK).14 Recognizing the decreased therapeutic efficacy and increased toxicity associated with the nonspecific accumulation of therapeutic agents in non-target tissues,17 an active tumor targetable peptide (IF7) was further decorated on the surface of ROSPCNP. IF7 is a namely tumorhoming peptide that specifically binds to annexin 1 (Anxa 1), which is abundant in the tumor vasculature and universal to all tumor types in mice and humans.18 In this case, the prepared nano-carrier was further endowed with the capability of precise delivery of both chemotherapeutics and photosensitizers to tumor site."
    }, {
      "heading" : "Method",
      "text" : "The detailed description of method sections has been described in the Supplementary Material."
    }, {
      "heading" : "Co-Polymer Synthesis and Nanoparticles Preparation",
      "text" : "The smart polymer mPEG−PLA-TK-DOX was synthesized by esterification reaction between thioketal, DOX, and mPEGPLA-COOH (Figure S1). ROSPCNP was then developed by the water-in-oil-in-water double emulsion and solvent diffusion evaporation approach. For decoration of IF7 peptides, amidation reaction was performed under the catalyzation of EDC/NHS."
    }, {
      "heading" : "Characterization of NPs",
      "text" : "Physicochemical properties of ROSPCNP and IF7-ROSPCNP were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), and high performance liquid chromatography (HPLC) chromatograms. Drug release experiments were performed under the condition of 100 rpm and 37 °C with PBS supplementing with or without H2O2 was applied as the medium. Moreover, stability of nanoparticles were further studied by protein adsorption assay and determination of the particle size changes after incubating ROSPCNP and IF7-ROSPCNP in DMEM containing 10% FBS."
    }, {
      "heading" : "Cell Uptake Assay",
      "text" : "Photoactivity of ROSPCNP in vitro was studied by determining the singlet oxygen generation (SOG) efficiency and reactive oxygen species (ROS). For cellular assay, 5 × 104 MCF-7/ADR cells or HUVEC cells were inoculated in 12-well plates and treated by different concentration of nanoparticles. After irradiated with a laser of 1.0 J/cm2, cellular uptake of different nanoparticles was evaluated by examining the fluorescence intensity of DOX.\nIntracellular distribution of drugs and cytotoxicity evaluation\n5 × 104 MCF-7/ADR cells or HUVEC cells were inoculated in dishes and treated by different concentration of nanoparticles. After irradiated with a laser of 1.0 J/cm2, the cellular distribution of ROSPCNP or IF7-ROSPCNPwas determined via a confocal laser scanning microscopy. For CCK-8 assay, 5 × 103 MCF-7/ADR cells or HUVEC cells were seeded into 96-well plates. After incubation with various nanoparticle formulations for 48 h, cells were exposed to a laser of 1.0 J/cm2. Then 10 μL CCK-8 solutions were added into each well and the absorbance was examined using a microplate reader at a wavelength of 450 nm."
    }, {
      "heading" : "Tumor targeting assay",
      "text" : "MCF-7/ADR tumor-bearing mice were established firstly by subcutaneous injection of MCF-7/ADR cells. After the tumor volumes achieved ~200 mm3, the tumor-bearing mice were randomly divided into two groups (n = 3) and respectively treated by DiR-labeled ROSPCNP and IF7-ROSPCNP. Then the tumor sites were irradiated with or without a laser of 10 J/cm2 and photographed by IVIS Spectrum system. Subsequently, the tumors were excised for section at a thickness of 10 μm. After staining by 5 μg/mL DAPI solutions and Alexa Fluor 647 antimouse CD31, the distribution of nanoparticles in tumor sites was observed under a confocal microscope."
    }, {
      "heading" : "Antitumor efficacy",
      "text" : "After the tumor size reached ~100 mm3, the mice were randomly divided into six groups (n = 6) and treated by different strategies, including saline, free DOX, ROSPCNP, ROSPCNP (+laser), IF7-ROSPCNP, and IF7-ROSPCNP (+laser). The drug was given at the dose of DOX 5.0 mg/kg. Then the weight, tumor size, and medium survival time were carefully measured and recorded. For safety evaluation, normal mice were also treated as above and without irradiation. Then the bodyweight changes were measured and main orangs were collected for histological evaluation."
    }, {
      "heading" : "Statistical analysis",
      "text" : "All the data were presented as mean ± standard deviation, and comparison among multiple groups was performed by oneway ANOVA analysis followed by Bonferroni test. Statistical significance was defined as P b 0.05."
    }, {
      "heading" : "Results",
      "text" : ""
    }, {
      "heading" : "Structural verification",
      "text" : "As shown in Figure 1, the peaks at 5.51 ppm and 1.64 ppm are the characteristic signals of -CH ̲ protons and − CH3 protons of PLA fraction contained in the mPEG-PLA-COOH. The −CH2 protons in the PEG block can be detected at 3.76 ppm. Importantly, the main characteristic peaks of mPEG-PLACOOH were preserved after the ROS-sensitive linkage was conjugated. Featured signals of TK groups were detected at 2.65 ppm and 3.32 ppm suggesting the successful synthesis of mPEGPLA-COO-ROS. For characterization of the finally obtained DOX prodrug, not only the featured signals of mPEG-PLACOOH and mPEG-PLA-TK were observable, but also the covalently linked DOX, indicating a successful synthesis of the smart polymer."
    }, {
      "heading" : "Characterization of nanoparticles",
      "text" : "Figure 2, B showed that both ROSPCNP and IF7-ROSPCNP have a core-shell architecture and uniform spherical appearance. The size of ROSPCNP was about 109.47 nm, with a PDI value of 0.147 (Figure 2, C). After the decoration with peptides, the average particle size was slightly enhanced to 116.27 nm. In the meanwhile, zeta potentials of ROSPCNP and IF7-ROSPCNP were − 28.42 mV and − 26.71 mV, respectively (Figure 2, D).\nHPLC chromatograms exhibited that the EE and DL of ROSPCNP for DOX were 98.24% and 1.18%, while the EE and\nDL of ROSPCNP for photosensitizers were 42.23% and 0.42%. Additionally, the functionalization of peptides has no significant effect on the drug-loading ability of nanoparticles, with the EE and DL of DOX for IF7-ROSPCNP were 98.17% and 1.21% while that of photosensitizers for IF7-ROSPCNP were 41.47% and 0.41%. Furthermore, encapsulation efficiency of catalase in ROSPCNP and IF7- ROSPCNP were 14.76% and 13.81%."
    }, {
      "heading" : "Drug release behavior",
      "text" : "Figure S2 showed that release of photosensitizers from ROSPCNP and IF7-ROSPCNP were almost the same and displayed a controlled release pattern. After incubated the nanoparticles with PBS containing 100 μM H2O2, an obvious initial burst release pattern was achieved with complete PS release was obtained at 12 h around. Nonetheless, release of photosensitizers from IF7-ROSPCNP (−catalase) can be depicted with a relative flat curve when compared with the catalase contained ones (Figure 2, E). For DOX release, Figure 3, A exhibited that IF7-ROSPCNP (+catalase) in the absence of H2O2 displayed negligible drug release while initial burst release pattern could be observed when incubated the nanoparticles with the medium containing H2O2. Release of DOX from IF7-ROSPCNP (−catalase) in PBS containing H2O2, was also investigated. Results exhibited that a controlled release pattern was achieved by IF7-ROSPCNP (−catalase) that was mainly because the structure of nanoparticles was not completely disrupted due to the absence of catalase."
    }, {
      "heading" : "Stability investigation",
      "text" : "For stability investigation, Figure 3, B showed that the size of both the nanoparticles did not change obviously within the determined days, suggesting a relative stable structure was remained during the experiments. Moreover, Figure 3, C displayed that ROSPCNP and IF7-ROSPCNP have an average BSA adsorption of 5.74% and 6.31%, which have no significant difference to that of general drugs unloaded PLA nanoparticles (5.51%)."
    }, {
      "heading" : "Photoactivity evaluation",
      "text" : "As shown in Figure S3,A, there was no significant difference in the SOG yield between free PS and ROSPCNP in DMSO, suggesting that the entrapment of photosensitizers by nanoparticles did not affect the photoactivity of photosensitizers. However, the SOG yield of ROSPCNP in aqueous media was approximately 12-fold higher than that of free PS due to the improved watersolubility of PS after entrapment by nanoparticles (Figure S3, B).\nStudies of the intracellular H2O2 levels revealed that strong fluorescence could be observed inMCF-7/ADR cells while not the HUVEC cells. Moreover, the tumor cells pretreated with nacetylcysteine (NAC), an ROS scavenger, displayed an obvious weaker fluorescence than the untreated ones. These results together confirmed the presence of endogenous H2O2 in MCF-7/ADR cells (Figure S4). We then investigated the SOG efficiency of nanoparticles in cancer cells by examination of the produced\nreactive oxygen species (ROS). Results showed that, in contrast to the cells in the absence of irradiation,MCF-7/ADR cells pretreated with ROSPCNP or IF7-ROSPCNP exhibited stronger fluorescent intensity post irradiation with a laser (Figure 3, D and E). Moreover, the cells treated by catalase uncontained nanoparticles displayed a relative weaker signal compared with the groups treated by catalase contained nanoparticles, demonstrating the favorable role of catalase in ROS production."
    }, {
      "heading" : "Cellular association of nanoparticles",
      "text" : "After incubated MCF-7/ADR cells or HUVEC cells with IF7-ROSPCNP (200 μg/mL), the fluorescence increased gradually along with the incubation time and reached a maximum at 3 h (Figure S5). To study the effect of IF7 peptides on cellular uptake of nanoparticles, the peptide unmodified nanoparticles were also subjected to cell uptake assay. After 3 h of incubation, stronger fluorescent intensity could be observed in both MCF-7/ ADR cells and HUVEC cells that incubated with IF7-ROSPCNP when compared to the cells treated by ROSPCNP (Figure 4, A and B). These results together indicated an excellent tumor cells and angiogenesis dual targetable for IF7 peptide. Furthermore, the internalized nanoparticles amount increased commensurately with the nanoparticle concentration, demonstrating a concentration-dependent manner was involved. Of great importance, amount of the internalized nanoparticles reached maximum at the nanoparticle concentration of 200 μg/mL, because no\nsignificant difference was observed between the cells treated by 200 μg/mL and 300 μg/mL of ROSPCNP or IF7-ROSPCNP (Figure 4, C and D).\nWe further investigated the PCI effect on cellular uptake of nanoparticles. Results showed in Figure 5, A confirmed that both cells pre-treated with 200 μg/mL ROSPCNP were more sensitivity to PCI, with the fluorescent intensity was significantly enhanced after irradiation. Further quantitative analysis revealed the amount of cellular entrapped ROSPCNP after irradiation was 2.83 folds of the unirradiated ones for MCF-7/ADR cells, and 3.01 folds of the unirradiated ones for HUVEC cells (Figure 5, B and C). Moreover, cellular accumulation of ROSPCNP was further enhanced after decoration on its surface with IF7 peptides. More importantly, qualitative images exhibited that there was obviously more amount of DOX could be observed in the nuclei of cells post irradiation, suggesting that free DOX was released from the polymer after irradiation."
    }, {
      "heading" : "Intracellular distribution of drugs",
      "text" : "Results exhibited that nanoparticles actually had an obvious co-localization with lysosomes of both MCF-7/ADR cells (Figure 4, E) without irradiation. However, the IF7-ROSPCNP had a more distribution in cytoplasm of MCF-7/ADR cells or HUVEC cells when compared with the unmodified ROSPCNP, indicating a lysosomes escaping ability of the peptide functionalized nanoparticles. We next studied cellular distribution of drugs in the presence of irradiation. Results showed that in photochemically untreated cells, doxorubicin was mainly located in the cytoplasm. Thirty minutes after irradiation, the distribution of doxorubicin in cells was apparently enhanced and obviously improved in the nucleus, suggesting that NIR light can trigger more release of DOX."
    }, {
      "heading" : "Anti-proliferation assay",
      "text" : "We subsequently performed the CCK-8 assay to determine the anti-proliferation ability of such treatment strategy on MCF7/ADR and HUVEC cells. Consistent with above, results showed that the cell viability of MCF-7/ADR cells while not the HUVEC cells was affected negligibly after incubation with free DOX, suggesting no appreciable cytotoxicity of DOX to the drug resistant tumor cells at the tested concentrations. However, after the ROSPCNP treated MCF-7/ADR cells were irradiated by a laser, the ability of anti-growth of cancer cells was significantly enhanced and such capacity can be further improved by decoration with the IF7 peptides (Figure 6, A).\nProliferation of HUVEC cells was not effect obviously by the ROSPCNP and IF7-ROSPCNP without irradiation, because HUVEC cells are H2O2 scarce and the ROS linkage remains stable. Such results can be further explained by evaluation of cytotoxicity of ProDOX (mPEG-PLA-ROS-DOX) against HUVEC cells with or without the presence of H2O2. As shown in Figure S6, cells treated by ProDOX NP together with the presence of H2O2 exhibited obvious anti-proliferation effect same to the free DOX. In contrast, the ProDOX NP without the presence of H2O2 exhibited negligible cytotoxicity to HUVEC cells, suggesting an ideal safety of ProDOX NP for H2O2 scarced normal cells. However, for cells treated ROSPCNP or IF7-ROSPCNP plus irradiation, the growth was dramatically inhibited and results further confirmed that the peptides-functionalized nanoparticles are more effective that the unmodified ones (Figure 6, B)."
    }, {
      "heading" : "In vivo biodistribution",
      "text" : "As shown in Figure 7, A-E, when compared to the mice injected with DiR-labeled ROSPCNP, stronger fluorescence\nintensity could be observed in the tumor site of the mice treated by IF7-ROSPCNP, indicating that the IF7 peptide has a high affinity to tumor tissues. Subsequently, we further investigated the effect of PCI on promoting accumulation of nanoparticles in tumor sites. As demonstrated by the results, post irradiation with a laser, the amount of nanoparticles in tumor site of mice that treated by ROSPCNP or IF7-ROSPCNP was dramatically enhanced. Such results were further confirmed by the semiquantitative analysis and it showed that the fluorescence intensity of IF7-ROSPCNP at the tumor site was approximately\n2.8 folds of ROSPCNP, while the fluorescence intensity of IF7ROSPCNP (+Laser) was 2.7 folds of IF7-ROSPCNP (-Laser).\nWe further adopted immunofluorescence technique to observe the intratumoral distribution of nanoparticles (Figure 7, F). Surprisingly in IF7-ROSPCNP group, IF7 peptides significantly enhanced the tumor distribution of nanoparticles. More importantly, the PCI has an obvious effect on promoting tumor tissue penetration of nanoparticles since much stronger fluorescence signal can be detected after irradiation with a certain wave length of laser."
    }, {
      "heading" : "Antitumor efficacy",
      "text" : "As a typical chemotherapeutics-resistant cancer, the MCF-7/ ADR tumor-bearing mice administrated with free DOX displayed a negligible tumor inhibition effect while the mice given with ROSPCNP and IF7-ROSPCNP without a laser showed a weak inhibitory effect (Figure 8). However, after the mice treated by ROSPCNP were irradiated with a laser of 10 J/cm2, the anti-tumor effect of the nanoparticles was dramatically enhanced. Moreover, modification on the surface of ROSPCNP with IF7 peptide further enhanced the anti-tumor effect.\nTo optimize the therapeutic responses of tumors to PCI, the catalase were further entrapped into the inner core of IF7ROSPCNP.Result confirmed that the catalase-involved nanoparticle formulations exerted greater tumor growth inhibition ability than the catalase uncontained ones. Further survival investigation exhibited that the mice treated by catalase-involved nanoparticle formulations\nand irradiated with a laser achieved longer survival times than the catalase-uncontained ones. The survival time of each group post treatment was follows: saline (18 days), free DOX (25 days), ROSPCNPwithout laser (21 days), ROSPCNPwith laser (53 days), IF7-ROSPCNP without laser (23 days), catalase uncontained ROSPCNP with laser (32 days), and the catalase uncontained IF7-ROSPCNP with laser (41 days).\nFinally, the safety of IF7-ROSPCNP to normal tissues was evaluated. Figure 8, E displayed that the body weights of mice treated by ROSPCNP and IF7-ROSPCNP without irradiation did not display obvious changes while that of the mice treated by free DOX and common PLA-nanoparticles exhibited a significant decrease. Additionally, histopathological analysis revealed that the tissues of mice injected with ROSPCNP and IF7-ROSPCNP without irradiation did not exhibited any difference from the control group, suggesting a favorable safety of the developed nanoparticles."
    }, {
      "heading" : "Discussion",
      "text" : "The success of chemotherapy in cancer patients is significantly restricted by the development of drug resistance.19 Besides, drug resistance of cancer cells contributes to cancer recurrence and high mortality rates due to various mechanisms.20 In our preliminary experiment, MCF-7/ADR cells treated by free doxorubicin or encapsulated in nanoparticles did not show significant proliferation inhibition. Such results are agreement with previous reports, which have demonstrated that theMCF-7/ADR cells were overexpressed with P-gp and highly resistant to doxorubicin.21\nAs a similar photochemical reaction to PDT, the technology of PCI has been widely used to enhance the cellular internalization of drugs.4 In the present study, photosensitizers were co-entrapped into the inner core of IF7-ROSPCNP for highly efficacious combination PCI and chemotherapy. After the nanoparticles were entrapped by MCF-7/ADR cells or HUVEC cells and then irradiated with a laser, the fluorescent intensity of cells was significantly higher than that of cells unexposed to a laser. The enhanced cellular uptake further leaded to an improved cytotoxicity to tumor cells. Previous studies pointed out that PCI can be utilized to conquer the poor penetration of the drug into the tumor inner through the manner of tumor vasculature disruption.6,7 Our in vivo tumor distribution studies confirmed that penetration of nanoparticles into tumor parenchyma was signally enhanced post\nirradiation. Importantly, tumor vasculatures of those irradiated groups displayed obvious fractures.\nAlthough the PCI effect is in favor of improving cellular association of drugs, the limited tumor selectivity represents another significant obstacle. To improve the targeting efficacy of anticancer agents, surfacemodification-based active targeting strategy has been widely used for its plentiful advantages.12–14 IF7 is a carbohydrate ligand-mimicking 7-mer peptide, which can target Anxa1 with high affinity and specificity.18 This peptide was initially designed to be a tumor vasculature-targetablemolecule because theAnxa1 is a highly specific surfacemarker of tumor vasculature.18 However, increasing evidences demonstrated that Anxa1 are also abundant inmany types of cancer cells.18 Therefore, we conjugated IF7 peptides on the surface of ROSPCNP for tumor cells and tumor vasculature dualtargeting drug delivery. Our studies confirmed that uptake of ROSPCNP in both MCF-7/ADR cells and HUVEC cells could be significantly enhanced after decorationwith IF7 peptides.Moreover, in vivo targeting experiments further demonstrated that IF7 peptide was capable of leading to an obvious more accumulation of nanoparticles at tumor sites.\nUnwanted release of chemotherapeutics at unspecific site further impaired the therapeutic efficacy and resulted in severe side effects. As a parallel offshoot of nanotechnology, smart polymers capable of responding to the intrinsic tumor environment have been developed for efficient drug delivery.14 Herein, to endow the\ndoxorubicin with the capacity of “stimulus-responsive”, a ROScleavable linkage was firstly conjugated to the terminal of mPEGPLA-COOH. Under the normal physiological conditions, the developed IF7-ROSPCNP exhibited satisfactory stability with negligible doxorubicin release could be observed. However, initial burst release pattern could be obtained when incubated the nanoparticles with the medium containing H2O2. Intracellular distribution of doxorubicin further confirmed the on-demand drug release of IF7-ROSPCNP.Barely detectable fluorescent signal was observed in nucleus of cells that without the treatment of PCI. In contrast, the distribution of doxorubicin in the nucleus was apparently enhanced post photochemical therapy.\nSimilar to the photodynamic therapy, photochemical internalization is also the clinical modality that based on the interaction between photosensitizer, an appropriate excitation light, and oxygen (O2) molecules.\n6 However, almost all of solid tumor types are characterized by hypoxia, which is mainly resulted from an inadequate oxygen supply.8,9 Such hypoxic environment of tumors is detrimental to utilizing PCI that requires adequate of molecular oxygen.10 For combating this dilemma, catalase, which can catalyzed the intracellular H2O2 for continuous production of oxygen, was co-entrapped into the nanoparticles. Detection of ROS revealed that the catalase-contained nanoparticles exhibited obvious higher singlet oxygen generation efficiency than the catalase-unloaded. Moreover, the generated oxygen may exacted an adverse effect on the nanoparticulate structure and promote drugs release out from the inner core.\nIn conclusion, we have developed a versatile nanoplatform for against the multi-drug resistant tumor by combining PCI with chemotherapy. The nanoparticles remain a stable structure under normal physical condition and undergo a dramatically structure disruption after exposing to a certain intensity of laser and then released the free DOX. Cellular experiments demonstrated that the enhanced cellular uptake of nanoparticles was exactly mediated by IF7 peptide or PCI effect, which leaded to a significant improved cytotoxicity to tumor cells. Tumor targeting assay and anti-tumor evaluation further confirmed the unique advantages of our drug delivery strategy in enhancing tumor site accumulation of nanoparticles and penetrating into tumor inner. Summary, the strategy of co-delivery of photosensitizers and chemotherapeutics using the smart nano-carrier developed here for combination therapy holds great potential in the treatment of drug resistant cancer."
    }, {
      "heading" : "Appendix A. Supplementary data",
      "text" : "Supplementary data to this article can be found online at https://doi.org/10.1016/j.nano.2019.03.007."
    } ],
    "references" : [ {
      "title" : "Harnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo-chemotherapy",
      "author" : [ "G Pasparakis", "T Manouras", "M Vamvakaki", "P. Argitis" ],
      "venue" : "Nat Commun",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2014
    }, {
      "title" : "Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle  with optimal size for combinational treatment of breast cancer and lung metastasis",
      "author" : [ "R Liu", "W Xiao", "C Hu", "R Xie", "H. Gao" ],
      "venue" : "J Control Release",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2018
    }, {
      "title" : "Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization",
      "author" : [ "PK Selbo", "K Sandvig", "V Kirveliene", "K. Berg" ],
      "venue" : "Biochim Biophys Acta 2000;1475:307-13",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2000
    }, {
      "title" : "Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells",
      "author" : [ "A Dietze", "A Bonsted", "A Høgset", "K. Berg" ],
      "venue" : "Photochem Photobiol 2003;78:283-9",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2003
    }, {
      "title" : "Lightcontrolled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization – a minimally invasive cancer stem cell-targeting strategy",
      "author" : [ "M Bostad", "CE Olsen", "Q Peng", "K Berg", "A Høgset", "PK. Selbo" ],
      "venue" : "J Control Release",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2015
    }, {
      "title" : "Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model",
      "author" : [ "Castano AP", "Mroz P", "WuMX", "Hamblin MR" ],
      "venue" : null,
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2008
    }, {
      "title" : "Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor",
      "author" : [ "Henderson BW", "Fingar VH" ],
      "venue" : "Cancer Res",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 1987
    }, {
      "title" : "CD24 is an effector of HIF-1-driven primary tumor growth and metastasis",
      "author" : [ "S Thomas", "MA Harding", "SC Smith", "JB Overdevest", "MD Nitz", "HF Frierson" ],
      "venue" : "Cancer Res",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2012
    }, {
      "title" : "Treatment resistance of solid tumors: role of hypoxia and anemia",
      "author" : [ "P Vaupel", "O Thews", "M. Hoeckel" ],
      "venue" : "Med Oncol",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2001
    }, {
      "title" : "An H O -responsive nanocarrier for dual-release of platinum anticancer drugs and O : controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells",
      "author" : [ "H Chen", "W He", "Z. Guo" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2014
    }, {
      "title" : "A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan",
      "author" : [ "CunX", "S Ruan", "J Chen", "L Zhang", "J Li", "HeQ" ],
      "venue" : "Acta Biomater 2016;31:186-96",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2016
    }, {
      "title" : "Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumormicroenvironment sensitive penetration and diagnosis of glioma",
      "author" : [ "S Ruan", "Q He", "H. Gao" ],
      "venue" : "Nanoscale",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2015
    }, {
      "title" : "D-T7 peptide modified PEGylated bilirubin nanoparticles loaded with Cediranib and paclitaxel for Antiangiogenesis and chemotherapy of glioma",
      "author" : [ "M Yu", "D Su", "Y Yang", "L Qin", "C Hu", "R Liu" ],
      "venue" : "ACS Appl Mater Interfaces 2018,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2018
    }, {
      "title" : "Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation",
      "author" : [ "S Ruan", "C Hu", "X Tang", "X Cun", "W Xiao", "K Shi" ],
      "venue" : "ACS Nano 2016;10:10086-98",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2016
    }, {
      "title" : "Recent advances in stimuli-responsive degradable block copolymer micelles: synthesis and controlled drug delivery applications",
      "author" : [ "Q Zhang", "NR Ko", "JK. Oh" ],
      "venue" : null,
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2012
    }, {
      "title" : "A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells",
      "author" : [ "MS Shim", "Y. Xia" ],
      "venue" : "Angew Chem Int Ed Engl 2013;52:6926-9",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2013
    }, {
      "title" : "Ligand-mediated and enzyme-directed precise targeting and retention for the enhanced treatment of glioblastoma",
      "author" : [ "S Ruan", "W Xiao", "C Hu", "H Zhang", "J Rao", "S Wang" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2034
    }, {
      "title" : "Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide",
      "author" : [ "S Hatakeyama", "K Sugihara", "TK Shibata", "J Nakayama", "TO Akamam", "N Tamura" ],
      "venue" : null,
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2011
    }, {
      "title" : "Functionalized graphene sheets for intracellular controlled release of therapeutic agents",
      "author" : [ "Z Tu", "V Wycisk", "C Cheng", "W Chen", "M Adeli", "R. Haag" ],
      "venue" : "Nanoscale",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2017
    }, {
      "title" : "Apoptosis and cancer chemotherapy",
      "author" : [ "Makin G", "Hickman JA" ],
      "venue" : "Cell Tissue Res",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2000
    }, {
      "title" : "Directed graphene-based Nanoplatforms for hyperthermia: overcoming multiple drug resistance",
      "author" : [ "Z Tu", "H Qiao", "Y Yan", "G Guday", "W Chen", "M Adeli" ],
      "venue" : "Angew Chem Int Ed Engl 2018;57:11198-202",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2018
    } ],
    "referenceMentions" : [ {
      "referenceID" : 3,
      "context" : "Under the photoactivation effect of photosensitizers, the membranes of organelles was disrupted, followed by driving intracellular accumulation of drugs and releasing drugs into the cytosol from endosomes or lysosomes.(4) Themost unique property of combining PCI with chemotherapy is increasing the availability of the",
      "startOffset" : 218,
      "endOffset" : 221
    }, {
      "referenceID" : 4,
      "context" : "Nanomedicine: NBM 2019;19:49-57 anticancer drug at its site of action.(5) Besides, such combination treatment strategy holds great potential in inducing antitumor immunity through a complex way.",
      "startOffset" : 70,
      "endOffset" : 73
    }, {
      "referenceID" : 5,
      "context" : "Besides, such combination treatment strategy holds great potential in inducing antitumor immunity through a complex way.(6) Although PCI has become a promising treatment option for drug-resistant cancers, tumor hypoxia severely impaired the therapeutic efficiency and hindered the further application of PCI in clinic.",
      "startOffset" : 120,
      "endOffset" : 123
    }, {
      "referenceID" : 6,
      "context" : "Although PCI has become a promising treatment option for drug-resistant cancers, tumor hypoxia severely impaired the therapeutic efficiency and hindered the further application of PCI in clinic.(7) The hypoxic environment of tumors is mainly caused by an inadequate oxygen supply and has been recognized as a characteristic feature of solid tumors.",
      "startOffset" : 194,
      "endOffset" : 197
    }, {
      "referenceID" : 7,
      "context" : "The hypoxic environment of tumors is mainly caused by an inadequate oxygen supply and has been recognized as a characteristic feature of solid tumors.(8) However, such hypoxic environment is highly detrimental to PCI application which requires sufficient molecular oxygen to continuously produce reactive oxygen species.",
      "startOffset" : 150,
      "endOffset" : 153
    }, {
      "referenceID" : 8,
      "context" : "However, such hypoxic environment is highly detrimental to PCI application which requires sufficient molecular oxygen to continuously produce reactive oxygen species.(9) To overcome such dilemma, efforts have beenmade to develop newO2-independent phototherapy agents.",
      "startOffset" : 166,
      "endOffset" : 169
    }, {
      "referenceID" : 10,
      "context" : "10 Another obstacle is the limited tumor selectivity which leads to poor drug delivery efficiency and limited tumor penetration.(11) To conquer these problems, active targeting strategy has been designed to enhance the delivery efficiency.",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 11,
      "context" : "To conquer these problems, active targeting strategy has been designed to enhance the delivery efficiency.(12) However, release of chemotherapeutics at unspecific site seemed to be unavoidable because it is impossible to accumulate all the administrated",
      "startOffset" : 106,
      "endOffset" : 110
    }, {
      "referenceID" : 12,
      "context" : "drugs to the targeted sites.(13) Stimuli-responsive polymeric nanocarriers are therefore developed for controlled transport of active compounds.",
      "startOffset" : 28,
      "endOffset" : 32
    }, {
      "referenceID" : 13,
      "context" : "Stimuli-responsive polymeric nanocarriers are therefore developed for controlled transport of active compounds.(14) Incorporation of cleavable linkages, which can be degraded in response to external stimuli, into drug delivery systems represents a promising method.",
      "startOffset" : 111,
      "endOffset" : 115
    }, {
      "referenceID" : 14,
      "context" : "Incorporation of cleavable linkages, which can be degraded in response to external stimuli, into drug delivery systems represents a promising method.(15) For example, ROScleavable linkage has been widely used because most tumor cells are under persistent endogenous ROS stress (50~100 μM).",
      "startOffset" : 149,
      "endOffset" : 153
    }, {
      "referenceID" : 15,
      "context" : "For example, ROScleavable linkage has been widely used because most tumor cells are under persistent endogenous ROS stress (50~100 μM).(16) Herein, we developed a novel nanoplatform which is ROS activable and capable of 1) simultaneously loading both of doxorubicin and photosensitizers (TPPS2a) for highly efficacious combination photodynamics therapy against the multi-drug resistant tumor, human breast cancer xenograft; 2) sealing the cytotoxicity of DOX by linking it to the terminal of mPEG-PLA-COOH via a ROS cleavable linkage; 3) encapsulating catalase which can catalyzed the intracellular H2O2 for continuous production of oxygen.",
      "startOffset" : 135,
      "endOffset" : 139
    }, {
      "referenceID" : 13,
      "context" : "The DOX contained co-polymer was developed via two steps of esterification reaction and introduction of the ROS-sensitive linkage thioketal (TK).(14) Recognizing the decreased therapeutic efficacy and increased toxicity associated with the nonspecific accumulation of therapeutic agents in non-target tissues,(17) an active tumor targetable peptide (IF7) was further decorated on the surface of ROSPCNP.",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 17,
      "context" : "IF7 is a namely tumorhoming peptide that specifically binds to annexin 1 (Anxa 1), which is abundant in the tumor vasculature and universal to all tumor types in mice and humans.(18) In this case, the prepared nano-carrier was further endowed with the capability of precise delivery of both chemotherapeutics and photosensitizers to tumor site.",
      "startOffset" : 178,
      "endOffset" : 182
    }, {
      "referenceID" : 18,
      "context" : "The success of chemotherapy in cancer patients is significantly restricted by the development of drug resistance.(19) Besides, drug resistance of cancer cells contributes to cancer recurrence and high mortality rates due to various mechanisms.",
      "startOffset" : 113,
      "endOffset" : 117
    }, {
      "referenceID" : 19,
      "context" : "Besides, drug resistance of cancer cells contributes to cancer recurrence and high mortality rates due to various mechanisms.(20) In our preliminary experiment, MCF-7/ADR cells treated by free doxorubicin or encapsulated in nanoparticles did not show significant proliferation inhibition.",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 20,
      "context" : "Such results are agreement with previous reports, which have demonstrated that theMCF-7/ADR cells were overexpressed with P-gp and highly resistant to doxorubicin.(21) As a similar photochemical reaction to PDT, the technology of PCI has been widely used to enhance the cellular internalization of drugs.",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 3,
      "context" : "As a similar photochemical reaction to PDT, the technology of PCI has been widely used to enhance the cellular internalization of drugs.(4) In the present study, photosensitizers were co-entrapped into the inner core of IF7-ROSPCNP for highly efficacious combination PCI and chemotherapy.",
      "startOffset" : 136,
      "endOffset" : 139
    }, {
      "referenceID" : 5,
      "context" : "Previous studies pointed out that PCI can be utilized to conquer the poor penetration of the drug into the tumor inner through the manner of tumor vasculature disruption.(6,7) Our in vivo tumor distribution studies confirmed that penetration of nanoparticles into tumor parenchyma was signally enhanced post irradiation.",
      "startOffset" : 170,
      "endOffset" : 175
    }, {
      "referenceID" : 6,
      "context" : "Previous studies pointed out that PCI can be utilized to conquer the poor penetration of the drug into the tumor inner through the manner of tumor vasculature disruption.(6,7) Our in vivo tumor distribution studies confirmed that penetration of nanoparticles into tumor parenchyma was signally enhanced post irradiation.",
      "startOffset" : 170,
      "endOffset" : 175
    }, {
      "referenceID" : 17,
      "context" : "IF7 is a carbohydrate ligand-mimicking 7-mer peptide, which can target Anxa1 with high affinity and specificity.(18) This peptide was initially designed to be a tumor vasculature-targetablemolecule because theAnxa1 is a highly specific surfacemarker of tumor vasculature.",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 17,
      "context" : "This peptide was initially designed to be a tumor vasculature-targetablemolecule because theAnxa1 is a highly specific surfacemarker of tumor vasculature.(18) However, increasing evidences demonstrated that Anxa1 are also abundant inmany types of cancer cells.",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 17,
      "context" : "However, increasing evidences demonstrated that Anxa1 are also abundant inmany types of cancer cells.(18) Therefore, we conjugated IF7 peptides on the surface of ROSPCNP for tumor cells and tumor vasculature dualtargeting drug delivery.",
      "startOffset" : 101,
      "endOffset" : 105
    }, {
      "referenceID" : 13,
      "context" : "As a parallel offshoot of nanotechnology, smart polymers capable of responding to the intrinsic tumor environment have been developed for efficient drug delivery.(14) Herein, to endow the",
      "startOffset" : 162,
      "endOffset" : 166
    }, {
      "referenceID" : 7,
      "context" : "6 However, almost all of solid tumor types are characterized by hypoxia, which is mainly resulted from an inadequate oxygen supply.(8,9) Such hypoxic environment of tumors is detrimental to utilizing PCI that requires adequate of molecular oxygen.",
      "startOffset" : 131,
      "endOffset" : 136
    }, {
      "referenceID" : 8,
      "context" : "6 However, almost all of solid tumor types are characterized by hypoxia, which is mainly resulted from an inadequate oxygen supply.(8,9) Such hypoxic environment of tumors is detrimental to utilizing PCI that requires adequate of molecular oxygen.",
      "startOffset" : 131,
      "endOffset" : 136
    }, {
      "referenceID" : 9,
      "context" : "Such hypoxic environment of tumors is detrimental to utilizing PCI that requires adequate of molecular oxygen.(10) For combating this dilemma, catalase, which can catalyzed the intracellular H2O2 for continuous production of oxygen, was co-entrapped into the nanoparticles.",
      "startOffset" : 110,
      "endOffset" : 114
    } ],
    "year" : 2019,
    "abstractText" : "Herein, a novel nano-system IF7-ROSPCNP, which is O2-evolving and reactive oxygen species (ROS)-activable, was developed for enhancing the combination chemotherapy and photodynamic therapy (PDT). The nanoparticles composed of photosensitizers (disulfonated meso-tetraphenylporphine, TPPS2a) and catalase in the inner core, doxorubicin (DOX) in the polymeric shell and functionalized on its surface with IF7 peptide, which specially bind to annexin 1. As confirmed that the structure of IF7-ROSPCNP was able to remain intact under normal physiological conditions. After IF7-ROSPCNP was selectively entrapped by the annexin 1-positive and ROS-abundant MCF-7/ADR cells, the shell of nanoparticles was ruptured and the entrapped photosensitizers were completely released out. Under irradiation, ROS was continuously produced and the DOX, which was conjugated to the terminal of polylactic copolymer (mPEG-PLA) by a ROS-cleavable linkage, was subsequently released. With such strategy, cellular uptake of drugs was dramatically improved resulted in an enhanced cytotoxicity and anti-tumor effect on drug resistant cancer. © 2019 Elsevier Inc. All rights reserved.",
    "creator" : "Elsevier"
  }
}